Nova Eye Medical to Present at Bell Potter Healthcare Conference
An announcement from Nova Eye Medical ( ($AU:EYE) ) is now available. Nova Eye Medical will present at the virtual Bell Potter Healthcare Conference 2026 on 17 November 2026 at
2d ago
Compare Stocks
Compare up to 40 stocks
Compared Stocks: 1 / 40
Comparison Results
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 ELXMF | Healthcare | $0.01 | 0.00 | $29.90M | -10.53 | ― | ― |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ELXMF | Nova Eye Medical | 0.01 | -0.24 | -94.40% |
| Name | Price | % Change | |
|---|---|---|---|
| ELXMF | $0.01 | -94.40% |
Custom Stock Latest News
Nova Eye Reports First iTrack Advance Sale in South KoreaNova Eye Medical ( ($AU:EYE) ) has provided an announcement. Nova Eye Medical develops, manufactures and sells ophthalmic treatment technologies and devices, including iTrack Advance, a minimally invasive glaucoma surgical
4d ago
Nova-Eye Medical Reports Director’s Indirect Shareholding ChangeThe latest update is out from Nova Eye Medical ( ($AU:EYE) ). Nova-Eye Medical Limited is the entity named in the notice; the release does not provide information on its
5d ago- Nova Eye Medical Reports New Director Has No Disclosed Interests
Nova Eye Medical ( ($AU:EYE) ) just unveiled an announcement. Nova Eye Medical Limited disclosed that Thomas George Duthy was appointed as a director on October 29, 2026. The notice
1w ago 
Nova Eye Medical Discloses Final Director Interest as Rahmon Coupe Departs BoardNova Eye Medical ( ($AU:EYE) ) has provided an announcement. Nova Eye Medical has reported the cessation of director Rahmon Coupe from the board as of 29 October 2026, detailing
2w ago
Nova Eye Investors Reject Director Re-election Despite Strong Backing for Other AGM ResolutionsNova Eye Medical ( ($AU:EYE) ) has shared an update. Nova Eye Medical has released the results of its 29 October 2026 annual general meeting, showing shareholders strongly backed most
2w ago
Nova Eye Medical Emphasizes Risk and Disclosure at 2026 AGMAn update from Nova Eye Medical ( ($AU:EYE) ) is now available. Nova Eye Medical used its 2026 Annual General Meeting presentation to outline corporate information and risk considerations, while
2w ago- Nova Eye Medical boosts glaucoma device growth as profitability improves
Nova Eye Medical ( ($AU:EYE) ) has shared an announcement. Nova Eye Medical has reported a strong year of commercial progress, with FY26 sales rising 26% to US$23.7 million and
2w ago 
Nova Eye Medical accelerates sales growth and posts positive cash flow in September quarterNova Eye Medical ( ($AU:EYE) ) has shared an announcement. Nova Eye Medical reported a strong September quarter, with total sales rising 30% year-on-year to US$6.3 million and last-twelve-month revenues
2w ago
Nova Eye Medical Schedules Investor Webinar to Review Quarterly ResultsNova Eye Medical ( ($AU:EYE) ) just unveiled an announcement. Nova Eye Medical will host an investor webinar on 2 November 2026 at 11:30 am AEDT, led by Managing Director
2w ago
Most Recent Earnings of Custom Stocks
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| ELXMF | Mar 2, 2027TBA | $29.90M | ― | ― | 0.12 | -10.53 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
- Comprehensive Analysis: Compare up to 40 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.
- Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.
- Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.
- Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.
- Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
Custom Stock - FAQ
Which Custom stocks have a "Strong Buy" analyst rating?
None of the selected stocks have a “Strong Buy” analyst rating consensus.
Are Custom stocks overpriced?
Nova Eye Medical's stock price is currently $0.01, and its average 12-month price target is N/A.
Which Custom stocks pay dividends?
Nova Eye Medical currently pays a dividend of $0.29 which represents an annual dividend yield of 0.00%. Nova Eye Medical's next Ex-dividend date is N/A and its next payout date is N/A.